Safety and Efficacy of CDB-2914 [ulipristal] in Comparison to Levonorgestrel for Emergency Contraception

Trial Profile

Safety and Efficacy of CDB-2914 [ulipristal] in Comparison to Levonorgestrel for Emergency Contraception

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Feb 2015

At a glance

  • Drugs Ulipristal (Primary) ; Levonorgestrel
  • Indications Pregnancy
  • Focus Registrational; Therapeutic Use
  • Sponsors HRA Pharma
  • Most Recent Events

    • 29 Jan 2010 Results published in the Lancet.
    • 11 Nov 2009 Actual end date (1 Apr 2009) added as reported by ClinicalTrials.gov.
    • 11 Nov 2009 Actual patient number (2321) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top